Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
Clinical trial NCT04678739 · COMPLETED
Trial details
- NCT number
- NCT04678739
- Sponsor
- M Abdur Rahim Medical College and Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-15
- Primary completion
- 2021-01-30
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.